Skip to main content
Signal8

Enhanced Provides Clinician-Led Access to Six New Peptides

$ENHAPress releaseNov 3, 2026, 8:15 AM ETRead the release

Enhanced Group began offering clinician-led, prescription-only access to six new peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax) through its Live Enhanced telehealth platform, following the HHS policy announced October 28, 2026. The new peptides complement the existing GHK-Cu and Sermorelin offering, with compounding handled by state-licensed U.S. pharmacies using FDA-registered, CGMP-compliant ingredients.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.